Dogwood Therapeutics, Inc.
DWTX
$4.90
$0.102.08%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 9.72M | 8.70M | 4.31M | 3.44M | 3.63M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.34M | 12.23M | 5.82M | 4.80M | 5.20M |
| Operating Income | -15.34M | -12.23M | -5.82M | -4.80M | -5.20M |
| Income Before Tax | -21.79M | -12.35M | -5.73M | -4.68M | -5.07M |
| Income Tax Expenses | 190.00K | -500.00 | -- | -- | -- |
| Earnings from Continuing Operations | -21.98 | -12.35 | -5.73 | -4.68 | -5.07 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -21.98M | -12.35M | -5.73M | -4.68M | -5.07M |
| EBIT | -15.34M | -12.23M | -5.82M | -4.80M | -5.20M |
| EBITDA | -11.95M | -7.54M | -- | -- | -- |
| EPS Basic | -17.94 | -11.17 | -6.31 | -5.87 | -6.68 |
| Normalized Basic EPS | -7.68 | -6.73 | -3.94 | -3.67 | -4.18 |
| EPS Diluted | -17.94 | -11.17 | -6.31 | -5.87 | -6.68 |
| Normalized Diluted EPS | -7.68 | -6.73 | -3.94 | -3.67 | -4.18 |
| Average Basic Shares Outstanding | 4.78M | 4.11M | 3.57M | 3.22M | 3.04M |
| Average Diluted Shares Outstanding | 4.78M | 4.11M | 3.57M | 3.22M | 3.04M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |